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background: The risk of recurrent cardiovascular (CV) events and bleeding remains high in stable myocardial infarction (MI) survivors in 
the US, England, Sweden and France [Rapsomaniki 2014]. However there are no prognostic models to support risk stratification of this 
population. The study aim was to develop and validate prognostic models for atherothrombotic events and bleeding in MI survivors in 
England.
Methods: We examined linked electronic health records (EHRs) [CALIBER 2000-2010] of patients who had survived 1 year after their last 
MI. Weibull parametric survival models including demographics, clinical history, clinical biomarkers and medications were used. Patients 
were grouped into risk strata for model calibration (see figure).
Results: 12,694 patients were in the development cohort from 159 general practices in South England and 5,613 in the validation cohort 
from 61 practices in the North. The 5-year Kaplan-Meier event estimates were 22.4% [95% CI: 21.4%-23.3%] for CV death/stroke/MI and 
7.2% [6.6%-7.8%] for hospitalised bleeding. In validation the c-indexes of the models were 0.75 [0.74-0.77] and 0.66 [0.63-0.70] and the 
hazard ratios for the high: low risk contrast were 11.5 [8.4-15.5] and 6.0 [3.6-10.2], respectively. The models were well calibrated (figure).
conclusion:  Prognostic models derived from population based EHRs allow us to risk stratify patients and may aid balancing benefits and 
harms for care and enable effective long-term clinical management after the acute MI.
 
